Research News

Genetic marker may help target aspirin for colorectal cancer

BMJ 2012; 345 doi: (Published 30 October 2012) Cite this as: BMJ 2012;345:e7281

OpenUrlCrossRefPubMedWeb of Science

Researchers from the US have found a link between the use of aspirin and better survival in adults with a genetically distinct type of colorectal cancer. Among 161 men and women whose cancers had a mutation in the PIK3CA gene, use …

View Full Text

Log in

Log in through your institution


* For online subscription